BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1357549)

  • 1. A PCR-based assay for the wild-type dystrophin gene transferred into the mdx mouse.
    Shrager JB; Naji A; Kelly AM; Stedman HH
    Muscle Nerve; 1992 Oct; 15(10):1133-7. PubMed ID: 1357549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCR analysis of dystrophin gene mutation and expression.
    Chamberlain JS; Farwell NJ; Chamberlain JR; Cox GA; Caskey CT
    J Cell Biochem; 1991 Jul; 46(3):255-9. PubMed ID: 1774226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoblast transfer and gene therapy in muscular dystrophies.
    Pagel CN; Morgan JE
    Microsc Res Tech; 1995 Apr; 30(6):469-79. PubMed ID: 7599358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel and simple method for genotyping the mdx mouse using high-resolution melt polymerase chain reaction.
    Trebbin AL; Hoey AJ
    Muscle Nerve; 2009 May; 39(5):603-8. PubMed ID: 19347923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA.
    Liu F; Nishikawa M; Clemens PR; Huang L
    Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
    Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
    J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
    Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
    J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
    Ragot T; Vincent N; Chafey P; Vigne E; Gilgenkrantz H; Couton D; Cartaud J; Briand P; Kaplan JC; Perricaudet M
    Nature; 1993 Feb; 361(6413):647-50. PubMed ID: 8437625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell transplantation and gene therapy in muscular dystrophy.
    Morgan JE; Partridge TA
    Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs.
    Acsadi G; Dickson G; Love DR; Jani A; Walsh FS; Gurusinghe A; Wolff JA; Davies KE
    Nature; 1991 Aug; 352(6338):815-8. PubMed ID: 1881437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of dystrophin gene mutations on the ERG in mice and humans.
    Cibis GW; Fitzgerald KM; Harris DJ; Rothberg PG; Rupani M
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3646-52. PubMed ID: 8258524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of the human dystrophin gene in mdx mouse skeletal muscles after ballistic transfection].
    Zelenin AV; Tarasenko OV; Kolesnikov VA; Mikhaĭlov VM; Kiselev AV; Baranov AN; Zelenina IA; Shafei RA; Ivashchenko TE; Evgrafov OV
    Genetika; 1998 Jun; 34(6):730-6. PubMed ID: 9719921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.
    Cox GA; Phelps SF; Chapman VM; Chamberlain JS
    Nat Genet; 1993 May; 4(1):87-93. PubMed ID: 8099842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle.
    Takeshima Y; Yagi M; Wada H; Matsuo M
    Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
    Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
    J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection.
    Yanagihara I; Inui K; Dickson G; Turner G; Piper T; Kaneda Y; Okada S
    Gene Ther; 1996 Jun; 3(6):549-53. PubMed ID: 8789805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.